-
US and Iran set for new talks after delay and deadly strikes
-
'Fired up' Spain ready to hit back, says De la Fuente
-
Germany into World Cup last 32 after late comeback, Dutch thrash Sweden
-
Germany come from behind to beat Ivory Coast and reach World Cup last 32
-
Albanian protests against Trump-linked resort swell
-
Clark clings to US Open lead as Scheffler charges
-
Burn dons cowboy boots as England unwind at World Cup
-
Miotti kicks Montpellier past Stade Francais into Top 14 final
-
France's Saliba says playing through the pain at World Cup
-
Iran says Hormuz closed as US-Iran deal falters over Lebanon
-
Counter-terror cops probe suspected anti-Muslim 'attacks' in Edinburgh
-
Bagnaia scorches to Czech MotoGP sprint victory, Bezzecchi suspended
-
Clark begins with bogey as McIlroy charges at US Open
-
Bolivia declares state of emergency, deploys military to quell protests
-
Specter of military escalation hangs over Colombia vote
-
Heavy metal: French town hosts medieval combat cage fights
-
Jamieson strikes as New Zealand eye series-levelling win despite Root heroics
-
Dutch swat Sweden as Germany, Ivory Coast eye World Cup knockout rounds
-
Netherlands thump Sweden in Houston to get World Cup liftoff
-
Scheffler opens with bogeys while McIlroy pars at windy US Open
-
Jamieson strikes as New Zealand eye series-levelling win against England
-
Brazil turn corner but tougher World Cup tests await
-
Ronaldinho coming out of retirement to join Italian 3rd division side
-
Cerundolo sees off Nakashima to set up Queen's final with Paul
-
Real Madrid say no contact with Bayern's Olise
-
Fritz takes down Zverev again to reach Halle final
-
Heartbreak for Japanese ace Satono Reve as Almeraq wins Royal Ascot thriller
-
Hendy quick-fire double sweeps Northampton to Prem title
-
Injured Doris out of Ireland's Nations Championship squad
-
'Not ridiculous': US dreams of World Cup glory after big wins
-
Meloni hits back as Trump escalates G7 photo spat
-
Kolbe star goal kicker as Springboks put 80 past Barbarians
-
Pogacar pips Van der Poel to Swiss Tour TT win
-
Bolivia declares state of emergency and begins removing protester roadblocks
-
Ukraine's Zelensky, top officials return Polish awards in WWII row
-
Cerundolo sees off Nakashima to reach Queen's final
-
Spanish judge bans PM's wife from leaving country
-
Jamieson double rocks England at start of record run-chase
-
Pegula powers past Sabalenka to reach Berlin final
-
Funeral for art giant David Hockney already taken place: publicist
-
Krishna and Jaiswal power India to ODI sweep against Afghanistan
-
Red heat alert issued for third of France, alcohol banned at music festival
-
Bagnaia scorches to Czech MotoGP sprint victory, Bezzecchi crashes
-
Iran says Hormuz closed again after Israel strikes Lebanon
-
Trump escalates spat with Italy’s Meloni over G7 photo claim
-
New Zealand set England record 463 to win second Test
-
Driver killed, 28 in hospital as UK train collision probed
-
Diplomats hold US-Iran preparatory discussions at Swiss retreat
-
New Zealand pile on the runs to leave England facing record chase in 2nd Test
-
Shahidi hits ton but India bowl out Afghanistan for 218
Medical Care Technologies (OTC PINK:MDCE) Discusses AI Vision Behind MDCE Melanoma Scan Imaging Platform
Company outlines long-term strategy surrounding AI-assisted imaging technologies and pre-screening wellness applications
MESA, AZ / ACCESS Newswire / June 4, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE), ("MDCE" or the "Company"), a technology company focused on AI-powered consumer applications and imaging technologies, today provided additional insight into the long-term strategic vision supporting the development of its MDCE Melanoma Scan Beta platform and broader AI imaging initiatives.

The Company stated that the MDCE Melanoma Scan Beta platform represents an important component of a larger technology strategy centered on AI-assisted imaging, image management systems, and future image analysis infrastructure. While the current platform remains in beta-stage development, Medical Care Technologies views the project as part of a broader effort to explore how artificial intelligence may be utilized to support future wellness-oriented imaging applications.
Medical Care Technologies believes advancements in artificial intelligence, computer vision technologies, image processing systems, and scalable software infrastructure are creating new opportunities for the development of intelligent imaging platforms capable of supporting a wide range of future use cases.
"Our vision extends beyond a single application," stated Marshall Perkins, Chief Executive Officer of Medical Care Technologies. "We are evaluating how AI-assisted imaging technologies, image analysis frameworks, and scalable software infrastructure may be applied across multiple future technology initiatives. The MDCE Melanoma Scan Beta platform serves as an important foundation within that broader strategy."
The Company noted that ongoing development activities are helping establish internal expertise and technical infrastructure related to imaging workflows, image management systems, software architecture, and future AI-assisted analytical capabilities.
Medical Care Technologies further stated that it believes imaging technologies may represent an important long-term category within preventative wellness, consumer health applications, and future digital monitoring platforms. As a result, the Company intends to continue evaluating opportunities involving AI-assisted imaging systems and related technology initiatives as part of its broader innovation strategy.
The Company emphasized that its current efforts remain focused on development, testing, refinement, and evaluation activities associated with the MDCE Melanoma Scan Beta platform. Future technology initiatives, expansion opportunities, and potential applications remain subject to ongoing research, development progress, resource availability, regulatory considerations, and market conditions.
"Our objective is to build a technology foundation that supports innovation across multiple future opportunities," added Perkins. "We believe the convergence of artificial intelligence, imaging technologies, and scalable software platforms may create meaningful opportunities for continued development and exploration."
Medical Care Technologies expects to continue providing shareholders with updates regarding platform development activities, AI imaging initiatives, testing programs, infrastructure expansion efforts, and broader technology strategy milestones as they occur.
The MDCE Melanoma Scan Beta platform remains in beta-stage development and is not intended to diagnose, treat, cure, or prevent any disease or medical condition. The platform has not been reviewed or cleared by the U.S. Food and Drug Administration.
About Medical Care Technologies Inc.
Medical Care Technologies Inc. is a technology company focused on AI-powered consumer applications, imaging technologies, wellness platforms, authentication technologies, and digital innovation initiatives. The Company continues to evaluate opportunities involving artificial intelligence, imaging systems, software development, and emerging technology applications.
Investor / Media Contact:
Medical Care Technologies Inc.
1910 S Stapley Drive
Suite 221
Mesa, AZ 85204
+1 480-645-0750
[email protected]
X: https://x.com/medicalcaretech
Website: https://medicalcaretechnologies.com/
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the federal securities laws. These statements involve risks and uncertainties that could cause actual results to differ materially from those projected. Forward-looking statements include, but are not limited to, statements regarding future development initiatives, AI imaging technologies, technology strategy, testing plans, commercialization opportunities, platform expansion efforts, and future growth objectives. The Company undertakes no obligation to publicly update forward-looking statements except as required by applicable law.
SOURCE: Medical Care Technologies Inc.
View the original press release on ACCESS Newswire
N.Walker--AT